From Bleuler to DSM-V: Diagnosing schizophrenia;A szkizofrénia diagnózisa Bleulertől a DSM-V-ig

Neuropsychopharmacologia Hungarica

Volumn 13, Issue 4, 2011, Pages 193-203

  János, Réthelyi ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Biomarker; Bleuler; Categorical; Diagnosis; Dimensional; DSM V; Kraepelin; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL FEATURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE MARKER; DISEASE SEVERITY; DSM V; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 84858256624     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: 10.5706/nph201112002     Document Type: Review

References (67)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association Press, Washington, DC, 1994.
2. American Psychiatric Association (2011) DSM-5 Development. http://www.dsm5.org/Pages/Default.aspx
3. Amminger, G. P., Schafer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., Berger, G. E. (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry, 67:146-54.
4. Bakker, S. C., Hoogendoorn, M. L., Hendriks, J., Verzijlbergen, K., Caron, S., Verduijn, W., Selten, J. P., Pearson, P. L., Kahn, R. S., Sinke, R. J. (2007) The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes, Brain and Behavior, 6:113-119.
5. Balázs, J., Bitter, I., Hideg, K., Vitrai, J. (1998) A M.I.N.I. és a M.I.N.I. PLUSZ kérdo{double acute}ív magyar nyelvu{double acute} változatának kidolgozása. Psychiatria Hungarica, 13:160-168.
6. Bassett, A. S., Costain, G., Fung, W. L., Russell, K. J., Pierce, L., Kapadia, R., Carter, R. F., Chow, E. W., Forsythe, P. J. (2010) Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. J Psychiatr Res, 44:1005-9.
7. Bassett, A. S., Marshall, C. R., Lionel, A. C., Chow, E. W., Scherer, S. W. (2008) Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet, 17:4045-53.
8. Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., McCarthy, S., Sebat, J., Gage, F. H. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473:221-5.
9. Burdick, K. E., Goldberg, T. E., Funke, B., Bates, J. A., Lencz, T., Kucherlapati, R., Malhotra, A. K. (2007) DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr Res, 89:169-172.
10. Cahn, W., van Haren, N. E., Hulshoff Pol, H. E., Schnack, H. G., Caspers, E., Laponder, D. A., Kahn, R. S. (2006) Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. Br J Psychiatry, 189:381-2.
11. Carpenter, W. T., Jr., Heinrichs, D. W., Wagman, A. M. (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry, 145:578-83.
12. Chiang, C. H., Su, Y., Wen, Z., Yoritomo, N., Ross, C. A., Margolis, R. L., Song, H., Ming, G. L. (2011) Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry, 16:358-60.
13. Coelho, F. M., Reis, H. J., Nicolato, R., Romano-Silva, M. A., Teixeira, M. M., Bauer, M. E., Teixeira, A. L. (2008) Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation, 15:140-4.
14. Farkas, M., Petho, B., Tolna, J., Vizkelety, G., Czobor, P. (2007) [Changes of hallucination and delusion: the results of the 21-33 year follow-up of "Budapest 2000"]. Psychiatr Hung, 22:176-84.
15. Fusar-Poli, P., Stone, J. M., Broome, M. R., Valli, I., Mechelli, A., McLean, M. A., Lythgoe, D. J., O'Gorman, R. L., Barker, G. J., McGuire, P. K. (2011) Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. Arch Gen Psychiatry, 68:881-90.
16. Galderisi, S., Maj, M. (2009) Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry, 24:493-500.
17. Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., Gannon, B., Jones, D. H., Jennum, P., Jordanova, A., Jonsson, L., Karampampa, K., Knapp, M., Kobelt, G., Kurth, T., Lieb, R., Linde, M., Ljungcrantz, C., Maercker, A., Melin, B., Moscarelli, M., Musayev, A., Norwood, F., Preisig, M., Pugliatti, M., Rehm, J., Salvador-Carulla, L., Schlehofer, B., Simon, R., Steinhausen, H. C., Stovner, L. J., Vallat, J. M., den Bergh, P. V., van Os, J., Vos, P., Xu, W., Wittchen, H. U., Jonsson, B., Olesen, J. (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol, 21:718-779.
18. Huang, J. T., Leweke, F. M., Tsang, T. M., Koethe, D., Kranaster, L., Gerth, C. W., Gross, S., Schreiber, D., Ruhrmann, S., Schultze-Lutter, F., Klosterkotter, J., Holmes, E., Bahn, S. (2007) CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One, 2:e756.
19. Kalman, J., Kalman, S. (2011) The conceptual re-evaluation and therapeutic success in schizophrenia. Neuropsychopharmacol Hung, 13:249-256.
20. Kao, H. T., Cawthon, R. M., Delisi, L. E., Bertisch, H. C., Ji, F., Gordon, D., Li, P., Benedict, M. M., Greenberg, W. M., Porton, B. (2008) Rapid telomere erosion in schizophrenia. Mol Psychiatry, 13:118-9.
21. Keller, W. R., Fischer, B. A., Carpenter, W. T., Jr. (2011) Revisiting the diagnosis of schizophrenia: where have we been and where are we going? CNS Neurosci Ther, 17:83-8.
22. Kirkpatrick, B., Buchanan, R. W., Ross, D. E., Carpenter, W. T., Jr. (2001) A separate disease within the syndrome of schizophrenia. ArchGenPsychiatry, 58:165-171.
23. Kirkpatrick, B., Galderisi, S. (2008) Deficit schizophrenia: an update. World Psychiatry, 7:143-7.
24. Kuhn, T. A tudományos forradalnak szerkezete. Gondolat, Budapest, 1984.
25. Lakhan, S. E., Kramer, A. (2009) Schizophrenia genomics and proteomics: are we any closer to biomarker discovery? Behav Brain Funct, 5:2.
26. Leiser, S. C., Dunlop, J., Bowlby, M. R., Devilbiss, D. M. (2011) Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. Biochem Pharmacol, 81:1408-21.
27. Lindenmayer, J. P., Kahn, A. Pszichopatológia. In: LIEBERN-AN, J. A., STROUP, T. S., PERKINS, S. O. (Eds.), A szkizofrénia tankönyve. American Psychiatric Publishing, Inc., Washington, DC; 2006, pp.187-222.
28. Marchetto, M. C., Brennand, K. J., Boyer, L., Gage, F. H. (2011) Induced pluripotent stem cells (iPSC) and neurologic disease modeling: Progress and Promises. Hum Mol Genet.
29. Marchetto, M. C., Winner, B., Gage, F. H. (2010) Pluripotent Neuropsychopharmacologia Hungarica 2011. XIII. évf. 4. Szám stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet, 19:R71-6.
30. McCarthy, S. E., Makarov, V., Kirov, G., Addington, A. M., McClellan, J., Yoon, S., Perkins, D. O., Dickel, D. E., Kusenda, M., Krastoshevsky, O., Krause, V., Kumar, R. A., Grozeva, D., Malhotra, D., Walsh, T., Zackai, E. H., Kaplan, P., Ganesh, J., Krantz, I. D., Spinner, N. B., Roccanova, P., Bhandari, A., Pavon, K., Lakshmi, B., Leotta, A., Kendall, J., Lee, Y. H., Vacic, V., Gary, S., Iakoucheva, L. M., Crow, T. J., Christian, S. L., Lieberman, J. A., Stroup, T. S., Lehtimaki, T., Puura, K., Haldeman-Englert, C., Pearl, J., Goodell, M., Willour, V. L., Derosse, P., Steele, J., Kassem, L., Wolff, J., Chitkara, N., McMahon, F. J., Malhotra, A. K., Potash, J. B., Schulze, T. G., Nothen, M. M., Cichon, S., Rietschel, M., Leibenluft, E., Kustanovich, V., Lajonchere, C. M., Sutcliffe, J. S., Skuse, D., Gill, M., Gallagher, L., Mendell, N. R., Craddock, N., Owen, M. J., O'Donovan, M. C., Shaikh, T. H., Susser, E., Delisi, L. E., Sullivan, P. F., Deutsch, C. K., Rapoport, J., Levy, D. L., King, M. C., Sebat, J. (2009) Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet, 41:1223-7.
31. McGorry, P. D., Nelson, B., Amminger, G. P., Bechdolf, A., Francey, S. M., Berger, G., Riecher-Rossler, A., Klosterkotter, J., Ruhrmann, S., Schultze-Lutter, F., Nordentoft, M., Hickie, I., McGuire, P., Berk, M., Chen, E. Y., Keshavan, M. S., Yung, A. R. (2009) Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry, 70:1206-12.
32. McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S., Jackson, H. (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry, 59:921-8.
33. Miller, G., Holden, C. (2010) Psychiatry. Proposed revisions to psychiatry's canon unveiled. Science, 327:770-1.
34. Moskowitz, A., Heim, G. (2011) Eugen Bleuler's Dementia praecox or the group of schizophrenias (1911): a centenary appreciation and reconsideration. Schizophr Bull, 37:471-9.
35. Must, A., Janka, Z., Horvath, S. (2011) Schizophrenia, environment and epigenetics. Neuropsychopharm Hung, 13:211-217.
36. Nelson, B., Fornito, A., Harrison, B. J., Yucel, M., Sass, L. A., Yung, A. R., Thompson, A., Wood, S. J., Pantelis, C., McGorry, P. D. (2009) A disturbed sense of self in the psychosis prodrome: linking phenomenology and neurobiology. Neurosci Biobehav Rev, 33:807-17.
37. Pedrosa, E., Sandler, V., Shah, A., Carroll, R., Chang, C., Rockowitz, S., Guo, X., Zheng, D., Lachman, H. M. (2011) Development of Patient-Specific Neurons in Schizophrenia Using Induced Pluripotent Stem Cells. J Neurogenet.
38. Peralta, V., Cuesta, M. J. (2011) Eugen bleuler and the schizophrenias: 100 years after. Schizophr Bull, 37:1118-20.
39. Petho, B., Tolna, J., Tusnady, G., Farkas, M., Vizkeleti, G., Vargha, A., Czobor, P. (2008) The predictive validity of the Leonhardean classification of endogenous psychoses: a 21-33-year follow-up of a prospective study ("BUDAPEST 2000"). Eur Arch Psychiatry Clin Neurosci, 258:324-34.
40. Phillips, L. J., Leicester, S. B., O'Dwyer, L. E., Francey, S. M., Koutsogiannis, J., Abdel-Baki, A., Kelly, D., Jones, S., Vay, C., Yung, A. R., McGorry, P. D. (2002) The PACE Clinic: identification and management of young people at "ultra" high risk of psychosis. J Psychiatr Pract, 8:255-69.
41. Pini, S., Cassano, G. B., Dell'Osso, L., Amador, X. F. (2001) Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry, 158:122-5.
42. Porton, B., Delisi, L. E., Bertisch, H. C., Ji, F., Gordon, D., Li, P., Benedict, M. M., Greenberg, W. M., Kao, H. T. (2008) Telomerase levels in schizophrenia: a preliminary study. Schizophr Res, 106:242-7.
43. Reis, H. J., Nicolato, R., Barbosa, I. G., Teixeira do Prado, P. H., Romano-Silva, M. A., Teixeira, A. L. (2008) Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett, 439:157-9.
44. Rethelyi, J. M., Bakker, S. C., Polgar, P., Czobor, P., Strengman, E., Pasztor, P. I., Kahn, R. S., Bitter, I. (2010) Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Am J Med Genet B Neuropsychiatr Genet, 153B:792-801.
45. Rethelyi, J. M., Czobor, P., Polgar, P., Mersich, B., Balint, S., Jekkel, E., Magyar, K., Meszaros, A., Fabian, A., Bitter, I. (2011) General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia. Eur Arch Psychiatry Clin Neurosci, in press.
46. Ripke, S., Sanders, A. R., Kendler, K. S., Levinson, D. F., Sklar, P., Holmans, P. A., Lin, D. Y., Duan, J., Ophoff, R. A., Andreassen, O. A., Scolnick, E., Cichon, S., St Clair, D., Corvin, A., Gurling, H., Werge, T., Rujescu, D., Blackwood, D. H., Pato, C. N., Malhotra, A. K., Purcell, S., Dudbridge, F., Neale, B. M., Rossin, L., Visscher, P. M., Posthuma, D., Ruderfer, D. M., Fanous, A., Stefansson, H., Steinberg, S., Mowry, B. J., Golimbet, V., De Hert, M., Jonsson, E. G., Bitter, I., Pietilainen, O. P., Collier, D. A., Tosato, S., Agartz, I., Albus, M., Alexander, M., Amdur, R. L., Amin, F., Bass, N., Bergen, S. E., Black, D. W., Borglum, A. D., Brown, M. A., Bruggeman, R., Buccola, N. G., Byerley, W. F., Cahn, W., Cantor, R. M., Carr, V. J., Catts, S. V., Choudhury, K., Cloninger, C. R., Cormican, P., Craddock, N., Danoy, P. A., Datta, S., de Haan, L., Demontis, D., Dikeos, D., Djurovic, S., Donnelly, P., Donohoe, G., Duong, L., Dwyer, S., Fink-Jensen, A., Freedman, R., Freimer, N. B., Friedl, M., Georgieva, L., Giegling, I., Gill, M., Glenthoj, B., Godard, S., Hamshere, M., Hansen, M., Hansen, T., Hartmann, A. M., Henskens, F. A., Hougaard, D. M., Hultman, C. M., Ingason, A., Jablensky, A. V., Jakobsen, K. D., Jay, M., Jurgens, G., Kahn, R. S., Keller, M. C., Kenis, G., Kenny, E., Kim, Y., Kirov, G. K., Konnerth, H., Konte, B., Krabbendam, L., Krasucki, R., Lasseter, V. K., Laurent, C., Lawrence, J., Lencz, T., Lerer, F. B., Liang, K. Y., Lichtenstein, P., Lieberman, J. A., Linszen, D. H., Lonnqvist, J., Loughland, C. M., Maclean, A. W., Maher, B. S., Maier, W., Mallet, J., Malloy, P., Mattheisen, M., Mattingsdal, M., McGhee, K. A., McGrath, J. J., McIntosh, A., McLean, D. E., McQuillin, A., Melle, I., Michie, P. T., Milanova, V., Morris, D. W., Mors, O., Mortensen, P. B., Moskvina, V., Muglia, P., Myin-Germeys, I., Nertney, D. A., Nestadt, G., Nielsen, J., Nikolov, I., Nordentoft, M., Norton, N., Nothen, M. M., O'Dushlaine, C. T., Olincy, A., Olsen, L., O'Neill, F. A., Orntoft, T. F., Owen, M. J., Pantelis, C., Papadimitriou, G., Pato, M. T., Peltonen, L., Petursson, H., Pickard, B., Pimm, J., Pulver, A. E., Puri, V., Quested, D., Quinn, E. M., Rasmussen, H. B., Rethelyi, J. M., Ribble, R., Rietschel, M., Riley, B. P., Ruggeri, M., Schall, U., Schulze, T. G., Schwab, S. G., Scott, R. J., Shi, J., Sigurdsson, E., Silverman, J. M., Spencer, C. C., Stefansson, K., Strange, A., Strengman, E., Stroup, T. S., Suvisaari, J., Terenius, L., Thirumalai, S., Thygesen, J. H., Timm, S., Toncheva, D., van den Oord, E., van Os, J., van Winkel, R., Veldink, J., Walsh, D., Wang, A. G., Wiersma, D., Wildenauer, D. B., Williams, H. J., Williams, N. M., Wormley, B., Zammit, S., Sullivan, P. F., O'Donovan, M. C., Daly, M. J., Gejman, P. V. (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet, 43:969-976.
47. Sato, M. (2006) Renaming schizophrenia: a Japanese perspective. World Psychiatry, 5:53-5.
48. Singh, I., Rose, N. (2009) Biomarkers in psychiatry. Nature, 460:202-7.
49. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietilainen, O. P., Mors, O., Mortensen, P. B., Sigurdsson, E., Gustafsson, O., Nyegaard, M., Tuulio-Henriksson, A., Ingason, A., Hansen, T., Suvisaari, J., Lonnqvist, J., Paunio, T., Borglum, A. D., Hartmann, A., FinkJensen, A., Nordentoft, M., Hougaard, D., Norgaard-Pedersen, B., Bottcher, Y., Olesen, J., Breuer, R., Moller, H. J., Giegling, I., Rasmussen, H. B., Timm, S., Mattheisen, M., Bitter, I., Rethelyi, J. M., Magnusdottir, B. B., Sigmundsson, T., Olason, P., Masson, G., Gulcher, J. R., Haraldsson, M., Fossdal, R., Thorgeirsson, T. E., Thorsteinsdottir, U., Ruggeri, M., Tosato, S., Franke, B., Strengman, E., Kiemeney, L. A., Melle, I., Djurovic, S., Abramova, L., Kaleda, V., Sanjuan, J., de Frutos, R., Bramon, E., Vassos, E., Fraser, G., Ettinger, U., Picchioni, M., Walker, N., Toulopoulou, T., Need, A. C., Ge, D., Yoon, J. L., Shianna, K. V., Freimer, N. B., Cantor, R. M., Murray, R., Kong, A., Golimbet, V., Carracedo, A., Arango, C., Costas, J., Jonsson, E. G., Terenius, L., Agartz, I., Petursson, H., Nothen, M. M., Rietschel, M., Matthews, P. M., Muglia, P., Peltonen, L., St Clair, D., Goldstein, D. B., Stefansson, K., Collier, D. A. (2009) Common variants conferring risk of schizophrenia. Nature, 460:744-7.
50. Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O. P., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J. E., Hansen, T., Jakobsen, K. D., Muglia, P., Francks, C., Matthews, P. M., Gylfason, A., Halldorsson, B. V., Gudbjartsson, D., Thorgeirsson, T. E., Sigurdsson, A., Jonasdottir, A., Bjornsson, A., Mattiasdottir, S., Blondal, T., Haraldsson, M., Magnusdottir, B. B., Giegling, I., Moller, H. J., Hartmann, A., Shianna, K. V., Ge, D., Need, A. C., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Paunio, T., Toulopoulou, T., Bramon, E., Di Forti, M., Murray, R., Ruggeri, M., Vassos, E., Tosato, S., Walshe, M., Li, T., Vasilescu, C., Muhleisen, T. W., Wang, A. G., Ullum, H., Djurovic, S., Melle, I., Olesen, J., Kiemeney, L. A., Franke, B., Sabatti, C., Freimer, N. B., Gulcher, J. R., Thorsteinsdottir, U., Kong, A., Andreassen, O. A., Ophoff, R. A., Georgi, A., Rietschel, M., Werge, T., Petursson, H., Goldstein, D. B., Nothen, M. M., Peltonen, L., Collier, D. A., St Clair, D., Stefansson, K. (2008) Large recurrent microdeletions associated with schizophrenia. Nature, 455:232-6.
51. Steinberg, S., de Jong, S., Andreassen, O. A., Werge, T., Borglum, A. D., Mors, O., Mortensen, P. B., Gustafsson, O., Costas, J., Pietilainen, O. P., Demontis, D., Papiol, S., Huttenlocher, J., Mattheisen, M., Breuer, R., Vassos, E., Giegling, I., Fraser, G., Walker, N., Tuulio-Henriksson, A., Suvisaari, J., Lonnqvist, J., Paunio, T., Agartz, I., Melle, I., Djurovic, S., Strengman, E., Jurgens, G., Glenthoj, B., Terenius, L., Hougaard, D. M., Orntoft, T., Wiuf, C., Didriksen, M., Hollegaard, M. V., Nordentoft, M., van Winkel, R., Kenis, G., Abramova, L., Kaleda, V., Arrojo, M., Sanjuan, J., Arango, C., Sperling, S., Rossner, M., Ribolsi, M., Magni, V., Siracusano, A., Christiansen, C., Kiemeney, L. A., Veldink, J., van den Berg, L., Ingason, A., Muglia, P., Murray, R., Nothen, M. M., Sigurdsson, E., Petursson, H., Thorsteinsdottir, U., Kong, A., Rubino, I. A., De Hert, M., Rethelyi, J. M., Bitter, I., Jonsson, E. G., Golimbet, V., Carracedo, A., Ehrenreich, H., Craddock, N., Owen, M. J., O'Donovan, M. C., Ruggeri, M., Tosato, S., Peltonen, L., Ophoff, R. A., Collier, D. A., St Clair, D., Rietschel, M., Cichon, S., Stefansson, H., Rujescu, D., Stefansson, K. (2011) Common Variants at VRK2 and TCF4 Conferring Risk of Schizophrenia. Hum Mol Genet.
52. Stephan, K. E., Baldeweg, T., Friston, K. J. (2006) Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry, 59:929-39.
53. Stephan, K. E., Friston, K. J., Frith, C. D. (2009) Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull, 35:509-27.
54. Szily, E., Keri, S. (2009) Anomalous subjective experience and psychosis risk in young depressed patients. Psychopathology, 42:229-35.
55. Tandon, R., Nasrallah, H. A., Keshavan, M. S. (2009) Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res, 110:1-23.
56. Thompson, A., Nelson, B., Yung, A. (2011) Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study. Schizophr Res, 126:51-7.
57. Tolna, J., Peth, B., Farkas, M., Vizkeleti, G., Tusnady, G., Marosi, J. (2001) Validity and reliability of leonhard's classification of endogenous psychoses: preliminary report on a prospective 25- to 30-year follow-up study. J Neural Transm, 108:629-36.
58. Tringer, L. A pszichiátria tankönyve. Semmelweis Kiadó, Budapest, 1999.
59. Trixler, M., Tényi, T. Szkizofrénia, szkizotípiás és paranoid kórképek. In: FÜREDI, J., NÉMETH, A., TARISKA, P. (Eds.), A pszichiátria magyar kézikönyve. Medicina, Budapest; 2009, pp.263-285.
60. Uhlhaas, P. J., Singer, W. (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci, 11:100-13.
61. van Os, J. (2009a) A salience dysregulation syndrome. Br J Psychiatry, 194:101-3.
62. van Os, J. (2009b) 'Salience syndrome' replaces 'schizophrenia' in DSM-V and ICD-11: psychiatry's evidence-based entry into the 21st century? Acta Psychiatr Scand, 120:363-72.
63. van Os, J., Kapur, S. (2009) Schizophrenia. Lancet, 374:635-45.
64. Vereczkei, A., Mirnics, K. (2011) Genetic predisposition to schizophrenia: what did we learn and what does the future hold? Neuropsychopharm Hung, 13:205-210.
65. Walters, J. T., Corvin, A., Owen, M. J., Williams, H., Dragovic, M., Quinn, E. M., Judge, R., Smith, D. J., Norton, N., Giegling, I., Hartmann, A. M., Moller, H. J., Muglia, P., Moskvina, V., Dwyer, S., O'Donoghue, T., Morar, B., Cooper, M., Chandler, D., Jablensky, A., Gill, M., Kaladjieva, L., Morris, D. W., O'Donovan, M. C., Rujescu, D., Donohoe, G. (2010) Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry, 67:692-700.
66. Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jonsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., Fratiglioni, L., Jennum, P., Lieb, R., Maercker, A., van Os, J., Preisig, M., Salvador-Carulla, L., Simon, R., Steinhausen, H. C. (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol, 21:655-79.
67. Zhu, H., Lensch, M. W., Cahan, P., Daley, G. Q. (2011) Investigating monogenic and complex diseases with pluripotent stem cells. Nat Rev Genet, 12:266-75.